Home › Funds › PNC Financial Services › PLX
PNC Financial Services position in PLX
PROTALIX BIOTHERAPEUTICS INC · Health Care
Latest position (Q2 2026)20 sh
Reported value held$47
Portfolio Weight0.00%
First reportedQ4 2023
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 19 | $34 | New |
| Q2 2024 | 1.42K | $1.66K | New |
| Q3 2025 | 35 | $78 | New |
| Q4 2025 | 20 | $36 | Reduce |
| Q1 2026 | 20 | $43 | Hold |
| Q2 2026 | 20 | $47 | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding PLX
- BlackRock Inc 4.05M sh · $9.43M · Q2 2026
- Renaissance Technologies 1.10M sh · $2.55M · Q2 2026
- Geode Capital Management 980.00K sh · $2.28M · Q2 2026
- Northern Trust Corp 922.34K sh · $2.15M · Q2 2026
- Goldman Sachs Group 475.92K sh · $1.11M · Q2 2026
- Marshall Wace 452.76K sh · $1.05M · Q2 2026
- Citadel Advisors 379.43K sh · $884.07K · Q2 2026
- Vanguard Group 488.55K sh · $879.39K · Q4 2025
- BNY Mellon 232.99K sh · $542.87K · Q2 2026
- Charles Schwab Investment Management 180.38K sh · $420.29K · Q2 2026
- Millennium Management 171.53K sh · $399.68K · Q2 2026
- AQR Capital Management 167.83K sh · $391.04K · Q2 2026